Emphysematous changes refer to areas of lung tissue where the tiny air sacs (alveoli) have been destroyed, leaving behind enlarged, simplified airspaces that can no longer efficiently exchange oxygen. You’ll most often see this phrase on a CT scan report, where a radiologist has spotted regions of damaged lung tissue. The damage is permanent, but understanding what it means, what caused it, and how it’s managed can help you make sense of what comes next.
What Happens Inside the Lungs
Your lungs contain roughly 300 million alveoli, grape-like clusters surrounded by tiny blood vessels. Oxygen passes through these thin walls into your bloodstream, and carbon dioxide passes out. In emphysematous changes, the walls between alveoli break down, and several small sacs merge into one larger, less efficient space. This reduces the total surface area available for gas exchange.
The destruction involves three overlapping processes: cell death in the alveolar walls, breakdown of the structural proteins (especially elastin) that give lungs their springy recoil, and damage from unstable molecules called free radicals. Healthy lungs snap back after each breath like a rubber band. When elastin fibers fragment, the lungs lose that recoil and become floppy, trapping stale air inside instead of pushing it out. This trapped air is what doctors call hyperinflation.
Why It Appears on a CT Report
Radiologists identify emphysematous changes on high-resolution CT scans as areas of abnormally low density, meaning the scan picks up air where lung tissue should be. The appearance varies depending on the type of emphysema:
- Centrilobular (centriacinar): The most common pattern. It shows up as small, scattered dark spots in the center of the lung’s structural units, primarily in the upper portions of the lungs. Early on, the borders are fuzzy and hard to define. As the disease progresses, these dark areas expand and the surrounding healthy lung gets compressed, creating sharper boundaries.
- Panlobular (panacinar): Entire structural units of the lung are uniformly affected, giving a diffuse, washed-out appearance. This pattern has no strong preference for upper or lower lungs and is commonly linked to a genetic condition called alpha-1 antitrypsin deficiency.
- Paraseptal (distal acinar): Small cyst-like spaces appear along the outer edges of the lung, right next to the chest wall and along the tissue dividers (fissures) between lung lobes. This type often affects the upper lungs and can exist alongside centrilobular emphysema.
If your report mentions “emphysematous changes” without specifying a type, the radiologist likely saw scattered areas of low density suggesting early or mild tissue loss. The word “changes” rather than “emphysema” sometimes signals that the findings are subtle or developing.
Causes and Risk Factors
Long-term cigarette smoking is the most common cause. Smoke triggers an inflammatory cascade that damages alveolar walls over years or decades. Research on smokers shows that centrilobular emphysema in particular correlates strongly with pack-years, with affected individuals averaging about 21 more pack-years of smoking history than those without emphysema.
Alpha-1 antitrypsin deficiency is the primary genetic cause. The liver normally produces a protective protein that travels through the blood to shield the lungs from irritants like smoke, pollution, and dust. People with certain gene variants produce too little of this protein. About 9 in 10 people with the severe form of this deficiency who also smoke will develop emphysema. Even without smoking, repeated exposure to fumes, air pollution, or occupational dust can trigger lung damage in these individuals.
Aging itself contributes. With advancing age, elastin fibers in the alveoli naturally fragment, shifting the lungs toward greater compliance, meaning they stretch more easily but recoil less effectively. This is why mild emphysematous changes on a CT scan are not unusual in older adults, even those who never smoked.
How It Feels
Early emphysematous changes often produce no symptoms at all, which is why they’re frequently discovered incidentally on a scan done for another reason. As more tissue is lost, the hallmark symptom is breathlessness during physical activity. This happens because the lungs can’t efficiently move air out, so stale air accumulates and there’s less room for fresh, oxygen-rich air.
As hyperinflation worsens, it reshapes the chest itself. The rib cage gradually expands into what’s called a barrel chest, where the front-to-back depth approaches or equals the side-to-side width (a ratio above 0.9, compared to the normal oval shape). The ribs become more horizontal, the spaces between them widen, the collarbones ride higher, and the spine curves forward. People with significant hyperinflation instinctively lean forward with hands on their knees or a table during episodes of breathlessness, a posture called the tripod position, because it mechanically helps the diaphragm work more efficiently.
Hyperinflation also gets worse during exercise and during flare-ups, which is why activities that used to be manageable can suddenly feel impossible during a chest infection.
Confirming the Diagnosis
A CT scan shows the structural damage, but a breathing test called spirometry confirms whether that damage is affecting airflow. The key measurement is the ratio between how much air you can force out in one second and the total amount you can blow out in one full breath. A ratio below 0.7 after inhaling a bronchodilator confirms airflow obstruction, which is the defining feature of COPD. Current clinical guidelines recommend using this fixed 0.7 cutoff rather than age-adjusted values.
Doctors assess overall severity using more than just lung function. A scoring system called the BODE index combines four measurements: body mass index, airflow obstruction (that spirometry number), degree of breathlessness in daily life, and how far you can walk in six minutes. This composite gives a more complete picture of prognosis than any single test. People with panlobular emphysema, for instance, tend to have lower body weight, while those with centrilobular emphysema tend to show more inflammation markers in their blood.
Possible Complications
When alveolar walls break down extensively, the enlarged airspaces can merge into large air-filled pockets called bullae. Giant bullous emphysema is defined by bullae occupying at least one-third of one side of the chest, compressing the healthy lung tissue around them. These bullae don’t participate in oxygen exchange, so they essentially steal space from working lung.
Bullae also raise the risk of spontaneous pneumothorax, where air leaks from the lung into the chest cavity. This can happen on its own, during a lung infection, or if mechanical ventilation is needed for another reason. Symptoms of a pneumothorax include sudden sharp chest pain and worsening breathlessness. Bullae can also become infected, causing chest pain, coughing up blood, and worsening oxygen levels.
How Emphysematous Changes Are Managed
The damage to alveolar walls is irreversible, so treatment focuses on slowing further destruction, relieving symptoms, and maintaining physical function. Quitting smoking is the single most impactful intervention for anyone who still smokes, because it halts the primary inflammatory trigger.
Pulmonary rehabilitation, a structured program of supervised exercise and education, produces measurable improvements regardless of how severe the disease is. In clinical data, participants improved their six-minute walking distance by an average of about 52 meters, with the most impaired patients gaining roughly 80 meters. Quality-of-life scores improved significantly across nearly every domain measured: physical function, social function, vitality, emotional well-being, and pain. People with the worst breathlessness at the start experienced the greatest reductions in shortness of breath. These improvements exceeded the threshold considered clinically meaningful in every severity group.
For advanced emphysema with severe hyperinflation, lung volume reduction procedures can help. These involve removing or blocking off the most damaged portions of lung so that healthier tissue can expand and the diaphragm can work more effectively. Eligibility is specific: lung function typically needs to fall between 20% and 45% of predicted, with significant air trapping (residual volume at least 150% of predicted) and CT evidence showing at least 20% tissue destruction in the targeted lobe. Candidates need to be managing their symptoms despite standard treatment and cannot have had frequent flare-ups in the past year.
Supplemental oxygen becomes appropriate when blood oxygen levels drop below a certain threshold, particularly during activity or sleep. Inhaled medications that open the airways or reduce inflammation help manage day-to-day symptoms, though they don’t reverse the underlying tissue loss.